This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Orchard Therapeutics North America, a foreign-owned for-profit organization. The contract has a period of performance from February 15, 2025 to February 14, 2030 and a ceiling value of $225,000.00.
The contract is for 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, to be provided under the Federal Supply Schedule program. As a multiple award Federal Supply Schedule contract, this allows the VA and other federal agencies to procure the specified pharmaceutical and hematology-related products from Orchard Therapeutics North America as needed. The contract does not utilize any set-asides. Relevant details on specific task orders, pricing, and the original solicitation were not provided in the information given.
Generated 2/12/25, 9:07 AM